DGNMF Financials: Diagnamed Holdings Corp. AI Analysis

Home

Stock

DGNMF

Financials

DGNMF Financial

Diagnamed Holdings Corp.

$0.08

-1.79%

$0

At close: Mar 24, 16:00:00 GMT-4

$0.08

Pre-market: Mar 25, 05:51:20 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$0.0836

Open

$0.085

Day's Range

$0.0788 - $0.1025

52 week range

$0.0136 - $0.1851

Volume

5.0K

Avg.Volume

128.1K

Dividend yield

EPS (TTM)

-0.01

Market Cap

$9.3M

What is Diagnamed Holdings Corp.?

DiagnaMed Holdings Corp. engages in providing artificial intelligence (AI) healthcare solutions. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2022-11-08. The firm delivers technology solutions for the cleantech and life sciences industries, with a focus on hydrogen production and artificial intelligence (AI)-driven drug discovery and diagnostics. The firm is focused on the commercialization of two technologies, such as a proprietary electromagnetic heating technology enabling hydrogen production from petroleum reservoirs and natural hydrogen fields, and BRAIN AGE BRAIN HEALTH, a proprietary brain health AI platform for the healthcare market. Its Brain Tremor is an investigating technological application that monitors, collects and uses individual information to detect tremors, and measure cognitive and brain activity in patients with neurological disorders. BRAIN AGE Brain Health is a brain health AI platform that aims to predict and monitor brain age and provide actionable insights into mental health and neurodegenerative disorders.



Features

AI Copilot for Stock & Crypto

Resources

Market

Income

Balance sheet

Cash flow

Annual

Quarterly

DGNMF Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	09/30/2025	09/30/2024	09/30/2023	09/30/2022	09/30/2021
Revenue	0	0	0	--	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	0	0	0	0	0	0
Research & Development	0	0	0	0	0	0
Operating Expenses	1	1	0	1	1	1
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-1	-1	0	-1	-1	-1
Income Tax Expense	--	--	--	--	--	--
Net Income	-1	-1	0	-1	-1	-1
Net Income Growth	--	--	-100%	0%	0%	--
Shares Outstanding (Diluted)	113.75	93.36	80.05	78.19	76.05	76.22
Shares Change (YoY)	41%	17%	2%	3%	0%	--
EPS (Diluted)	-0.01	-0.01	0	-0.01	-0.01	-0.02
EPS Growth	62%	138%	-61%	9%	-42%	--
Free Cash Flow	0	0	0	-1	0	0
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	--	0%	0%
Profit Margin	0%	0%	0%	--	0%	0%
Free Cash Flow Margin	0%	0%	0%	--	0%	0%
EBITDA	--	--	--	--	--	--
EBITDA Margin	--	--	--	--	--	--
D&A For EBITDA	--	--	--	--	--	--
EBIT	-1	-1	0	-1	-1	-1
EBIT Margin	0%	0%	0%	--	0%	0%
Effective Tax Rate	--	--	--	--	--	--

Follow-Up Questions

What are Diagnamed Holdings Corp.'s key financial statements?



According to the latest financial statement (Form-10K), Diagnamed Holdings Corp. has a total asset of $0, Net loss of $-1

What are the key financial ratios for DGNMF?



Diagnamed Holdings Corp.'s Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is Diagnamed Holdings Corp.'s revenue broken down by segment or geography?



Diagnamed Holdings Corp. largest revenue segment is Jewellery, at a revenue of 115,191,000 in the most earnings release.For geography, United States is the primary market for Diagnamed Holdings Corp., at a revenue of 68,774,000.

Is Diagnamed Holdings Corp. profitable?



no, according to the latest financial statements, Diagnamed Holdings Corp. has a net loss of $-1

Does Diagnamed Holdings Corp. have any liabilities?



no, Diagnamed Holdings Corp. has liability of 0

How many outstanding shares for Diagnamed Holdings Corp.?



Diagnamed Holdings Corp. has a total outstanding shares of 109.15

Diagnamed Holdings Corp. (DGNMF) Financial

DGNMF Stock Price Chart